A phase II study evaluating carboplatin/paclitaxel/pembrolizumab among newly diagnosed stage III/IV epithelial ovarian cancer patients receiving neoadjuvant chemotherapy followed by olaparib/pembrolizumab maintenance
Year: 2024
Type: article
Source: Gynecologic Oncology
Authors: Kaitlyn Kincaid, Peter Ketch, Alexandra North, Mary Chambers, Anna Wilbanks, Jennah Moore, Bailee Dover, Kathryn Lyle, Sejong Bae, Charles Leath, Rebecca Arend
Institution: University of Alabama at Birmingham
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403250678